Foresight Enterprise VCT Ord (FTF.L)
| Previous close | 57.50 |
| Open | 0.00 |
| Bid | 0.00 x 0 |
| Ask | 59.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 1,884 |
| Market cap | 157.479M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 19.17 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Issue of Equity
FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 Issue of EquityAllotment of Ordinary Shares15 April 2024 The Board of Foresight Enterprise VCT plc (“the Company”) is pleased to announce that 293,262 Ordinary Shares of 1p each in the capital of the Company (“the Shares”) were allotted on 15 April 2024 pursuant to the offer for subscription (“the Offer”) contained in the prospectus issued by the Company dated 13 October 2023. The Shares were issued at offer prices based on an unaudited net a
- GlobeNewswire
Portfolio Update: Sale of portfolio company Specac International delivers 10.6x return for Foresight Enterprise VCT PLC
The Board of Foresight Enterprise VCT Plc (the “Company”) is pleased to announce the successful sale of portfolio company Specac International Limited (“Specac”), a global leader in the manufacture of mass spectroscopy accessories. The transaction generated proceeds of £11.2 million at completion, implying a return of 10.6 times the original investment and an IRR of 34%. Prior to the sale of Specac Limited, the Company’s NAV per ordinary share stood at 60.6p, to which the exit will add 0.5p, giv
- GlobeNewswire
Offer Update
FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 OFFER FOR SUBSCRIPTION - UPDATE30 JANUARY 2024 The Company published a prospectus on 13 October 2023, ("the Prospectus") containing an offer for subscription of up to £20 million with an over-allotment facility for a further £10 million through the subscription of up to a maximum of 70 million ordinary shares of 1p each ("the Offer"). Full details of the Offer are contained in the Prospectus. The Directors are pleased to announce that they ha
